In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange? is a research paper published in Hematology Transfusion and Cell Therapy (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
American Society of Hematology
Bristol-Myers Squibb Foundation
National Institutes of Health
FWCI
0.00
Citation Percentile
0.4%
Fields of Study
Keywords